Statistics
Publications
1
Citations
12
H-Index
1
Active since
2022
Affiliations
Rengui Saxu is an author at Tianjin University of Science and Technology specializing in oncology pharmacology, pharmacology, and oncology.
Publications per year
2022–2022
1
1
Losartan Alleviates the Side Effects and Maintains the Anticancer Activity of Axitinib
Ying Fu, Rengui Saxu, Kadir Ahmad Ridwan et al. · Molecules · 2022 · 12 citations · Full text
Medicine, Oncology, Pharmacology +17
1–1 of 1